vs

Side-by-side financial comparison of INTEST CORP (INTT) and PRO DEX INC (PDEX). Click either name above to swap in a different company.

INTEST CORP is the larger business by last-quarter revenue ($32.8M vs $18.7M, roughly 1.8× PRO DEX INC). PRO DEX INC runs the higher net margin — 11.7% vs 3.8%, a 7.9% gap on every dollar of revenue. On growth, PRO DEX INC posted the faster year-over-year revenue change (11.1% vs -10.3%). PRO DEX INC produced more free cash flow last quarter ($3.5M vs $-1.6M). Over the past eight quarters, PRO DEX INC's revenue compounded faster (14.3% CAGR vs 4.9%).

INTTEST Corp designs, manufactures and distributes precision test and process control solutions for the global semiconductor manufacturing ecosystem. Its offerings include thermal management systems, test interface hardware, and wafer handling tools, serving semiconductor fabs, chip design firms, and automotive and industrial electronics end segments.

Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.

INTT vs PDEX — Head-to-Head

Bigger by revenue
INTT
INTT
1.8× larger
INTT
$32.8M
$18.7M
PDEX
Growing faster (revenue YoY)
PDEX
PDEX
+21.5% gap
PDEX
11.1%
-10.3%
INTT
Higher net margin
PDEX
PDEX
7.9% more per $
PDEX
11.7%
3.8%
INTT
More free cash flow
PDEX
PDEX
$5.1M more FCF
PDEX
$3.5M
$-1.6M
INTT
Faster 2-yr revenue CAGR
PDEX
PDEX
Annualised
PDEX
14.3%
4.9%
INTT

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
INTT
INTT
PDEX
PDEX
Revenue
$32.8M
$18.7M
Net Profit
$1.2M
$2.2M
Gross Margin
45.4%
30.8%
Operating Margin
3.9%
17.5%
Net Margin
3.8%
11.7%
Revenue YoY
-10.3%
11.1%
Net Profit YoY
-17.4%
7.2%
EPS (diluted)
$0.10
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INTT
INTT
PDEX
PDEX
Q4 25
$32.8M
$18.7M
Q3 25
$26.2M
$18.5M
Q2 25
$28.1M
$17.5M
Q1 25
$26.6M
$17.4M
Q4 24
$36.6M
$16.8M
Q3 24
$30.3M
$14.9M
Q2 24
$34.0M
$15.0M
Q1 24
$29.8M
$14.3M
Net Profit
INTT
INTT
PDEX
PDEX
Q4 25
$1.2M
$2.2M
Q3 25
$-938.0K
$4.7M
Q2 25
$-503.0K
$1.2M
Q1 25
$-2.3M
$3.3M
Q4 24
$1.5M
$2.0M
Q3 24
$495.0K
$2.5M
Q2 24
$230.0K
$1.6M
Q1 24
$662.0K
$655.0K
Gross Margin
INTT
INTT
PDEX
PDEX
Q4 25
45.4%
30.8%
Q3 25
41.9%
29.0%
Q2 25
42.6%
19.9%
Q1 25
41.5%
33.3%
Q4 24
39.7%
30.2%
Q3 24
46.3%
34.6%
Q2 24
40.6%
27.2%
Q1 24
43.8%
28.0%
Operating Margin
INTT
INTT
PDEX
PDEX
Q4 25
3.9%
17.5%
Q3 25
-4.5%
16.8%
Q2 25
-3.3%
7.7%
Q1 25
-10.8%
20.9%
Q4 24
5.7%
16.0%
Q3 24
1.6%
20.2%
Q2 24
1.0%
15.6%
Q1 24
1.6%
15.5%
Net Margin
INTT
INTT
PDEX
PDEX
Q4 25
3.8%
11.7%
Q3 25
-3.6%
25.3%
Q2 25
-1.8%
6.8%
Q1 25
-8.7%
18.8%
Q4 24
4.1%
12.1%
Q3 24
1.6%
16.6%
Q2 24
0.7%
10.6%
Q1 24
2.2%
4.6%
EPS (diluted)
INTT
INTT
PDEX
PDEX
Q4 25
$0.10
$0.66
Q3 25
$-0.08
$1.40
Q2 25
$-0.04
$0.33
Q1 25
$-0.19
$0.98
Q4 24
$0.13
$0.61
Q3 24
$0.04
$0.75
Q2 24
$0.02
$0.44
Q1 24
$0.05
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INTT
INTT
PDEX
PDEX
Cash + ST InvestmentsLiquidity on hand
$14.2M
$6.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$103.6M
$41.6M
Total Assets
$151.3M
$62.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INTT
INTT
PDEX
PDEX
Q4 25
$14.2M
$6.1M
Q3 25
$16.2M
$10.1M
Q2 25
$19.2M
$6.8M
Q1 25
$22.0M
$5.5M
Q4 24
$19.8M
$4.7M
Q3 24
$18.0M
$7.8M
Q2 24
$20.4M
$6.8M
Q1 24
$27.3M
$7.8M
Total Debt
INTT
INTT
PDEX
PDEX
Q4 25
Q3 25
$4.9M
Q2 25
$5.9M
$15.4M
Q1 25
$6.9M
Q4 24
$7.9M
Q3 24
$9.0M
Q2 24
$10.0M
$12.0M
Q1 24
$11.0M
Stockholders' Equity
INTT
INTT
PDEX
PDEX
Q4 25
$103.6M
$41.6M
Q3 25
$101.9M
$41.5M
Q2 25
$102.6M
$36.6M
Q1 25
$99.4M
$35.3M
Q4 24
$99.8M
$31.8M
Q3 24
$100.4M
$30.9M
Q2 24
$99.5M
$30.9M
Q1 24
$99.3M
$30.9M
Total Assets
INTT
INTT
PDEX
PDEX
Q4 25
$151.3M
$62.3M
Q3 25
$148.3M
$64.3M
Q2 25
$149.7M
$61.2M
Q1 25
$148.0M
$64.3M
Q4 24
$152.3M
$60.4M
Q3 24
$158.4M
$54.3M
Q2 24
$160.6M
$52.5M
Q1 24
$159.5M
$50.5M
Debt / Equity
INTT
INTT
PDEX
PDEX
Q4 25
Q3 25
0.05×
Q2 25
0.06×
0.42×
Q1 25
0.07×
Q4 24
0.08×
Q3 24
0.09×
Q2 24
0.10×
0.39×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INTT
INTT
PDEX
PDEX
Operating Cash FlowLast quarter
$-1.0M
$3.6M
Free Cash FlowOCF − Capex
$-1.6M
$3.5M
FCF MarginFCF / Revenue
-4.7%
18.8%
Capex IntensityCapex / Revenue
1.6%
0.4%
Cash ConversionOCF / Net Profit
-0.82×
1.63×
TTM Free Cash FlowTrailing 4 quarters
$5.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INTT
INTT
PDEX
PDEX
Q4 25
$-1.0M
$3.6M
Q3 25
$3.5M
$2.3M
Q2 25
$-688.0K
$-173.0K
Q1 25
$5.5M
$754.0K
Q4 24
$2.6M
$-4.2M
Q3 24
$4.2M
$1.9M
Q2 24
$-5.1M
$1.0M
Q1 24
$2.1M
$4.1M
Free Cash Flow
INTT
INTT
PDEX
PDEX
Q4 25
$-1.6M
$3.5M
Q3 25
$3.1M
$2.2M
Q2 25
$-1.1M
Q1 25
$5.3M
$574.0K
Q4 24
$2.4M
$-4.7M
Q3 24
$3.7M
$1.5M
Q2 24
$-5.4M
Q1 24
$1.7M
$4.0M
FCF Margin
INTT
INTT
PDEX
PDEX
Q4 25
-4.7%
18.8%
Q3 25
11.8%
11.9%
Q2 25
-4.1%
Q1 25
19.9%
3.3%
Q4 24
6.6%
-27.9%
Q3 24
12.4%
9.8%
Q2 24
-15.9%
Q1 24
5.8%
27.7%
Capex Intensity
INTT
INTT
PDEX
PDEX
Q4 25
1.6%
0.4%
Q3 25
1.6%
0.5%
Q2 25
1.6%
Q1 25
0.9%
1.0%
Q4 24
0.4%
3.2%
Q3 24
1.7%
2.9%
Q2 24
0.9%
Q1 24
1.1%
0.8%
Cash Conversion
INTT
INTT
PDEX
PDEX
Q4 25
-0.82×
1.63×
Q3 25
0.49×
Q2 25
-0.14×
Q1 25
0.23×
Q4 24
1.72×
-2.03×
Q3 24
8.58×
0.77×
Q2 24
-22.13×
0.66×
Q1 24
3.13×
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INTT
INTT

Environmental Technologies$8.3M25%
Semiconductor Market$6.9M21%
Thermal Testing Products$6.4M19%
Service And Other Products$4.8M15%
Oem Integrators And Distributor$3.5M11%
Semiconductor Production Test Products$3.0M9%

PDEX
PDEX

Segment breakdown not available.

Related Comparisons